Home » Topics » BioWorld Science, Patents

BioWorld Science, Patents
RSS

Czech scientists report novel dual PGE2 and NO production inhibitors

Oct. 3, 2012

The Vanderbilt University patents new mGlu5 receptor allosteric modulators

Oct. 3, 2012

Novel TRPM8 channel antagonists presented by Pfizer

Oct. 3, 2012

Pfizer discloses new antibacterial agents

Oct. 3, 2012

Biotie Therapies describes novel SSAO inhibitors

Oct. 2, 2012

Novel AMPK activators synthesized at GlaxoSmithKline

Oct. 2, 2012

Japanese researchers disclose new glucokinase activators

Oct. 2, 2012

Daiichi Sankyo divulges new Mdm2/p53 inhibitors

Oct. 2, 2012

GlaxoSmithKline patents new RIP-2 inhibitors

Oct. 2, 2012

Merck KGaA discloses novel agents for cancer

Oct. 2, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 11, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026